Relapse following successful electroconvulsive therapy for major depression: A meta-analysis

Neuropsychopharmacology

Volumn 38, Issue 12, 2013, Pages 2467-2474

  Jelovac, Ana ^a   Kolshus, Erik ^a   McLoughlin, Declan M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

depression; electroconvulsive therapy; meta analysis; relapse

Indexed keywords

AMITRIPTYLINE; IMIPRAMINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; ELECTROCONVULSIVE THERAPY; FOLLOW UP; HUMAN; MAJOR DEPRESSION; META ANALYSIS; MONOTHERAPY; PRIORITY JOURNAL; PSYCHOSIS; RECURRENCE RISK; RELAPSE; SENSITIVITY ANALYSIS;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; HUMANS; RECURRENCE; RISK FACTORS;

EID: 84888388708     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.149     Document Type: Article

References (37)

1. American Psychiatric Association (2001). The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. A Task Force Report of the American Psychiatric Association. 2nd edn. American Psychiatric Association: Washington, DC, USA.
2. Arfwidsson L, Arn L, Beskow J (1973). Chlorpromazine and the anti-depressive efficacy of electroconvulsive therapy. Acta Psychiatr Scand 49: 580-587.
3. Barton JL, Mehta S, Snaith RP (1973). The prophylactic value of extra ECT in depressive illness. Acta Psychiatr Scand 49: 386-392.
4. Borenstein M, Hedges L, Higgins J, Rothstein H (2011): Comprehensive Meta Analysis Version 2.2.064, Biostat: Engelwood, NJ, USA.
5. Bruce EM, Crone N, Fitzpatrick G, Frewin SJ, Gillis A, Lascelles CF et al (1960). A comparative trial of ECT and Tofranil. Am J Psychiatry 117: 76.
6. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
7. Dunne RA, McLoughlin DM (2012). Systematic review and metaanalysis of bifrontal electroconvulsive therapy versus bilateral and unilateral electroconvulsive therapy in depression. World J Biol Psychiatry 13: 248-258.
8. Eranti S, Mogg A, Pluck G, Landau S, Purvis R, Brown RG et al (2007). A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. Am J Psychiatry 164: 73-81. (Pubitemid 46154785)
9. Fekadu A, Wooderson SC, Markopoulo K, Donaldson C, Papadopoulos A, Cleare AJ (2009). What happens to patients with treatment-resistant depression A systematic review of medium to long term outcome studies. J Affect Disord 116: 4-11.
10. Flint AJ, Rifat SL (1998). Two-year outcome of psychotic depression in late life. Am J Psychiatry 155: 178-183. (Pubitemid 28074278)
11. Hamilton M (1974). Drug-resistant depressions: response to ECT. Pharmakopsychiatr Neuropsychopharmakol 7: 205-206.
12. Heijnen WT, Birkenhager TK, Wierdsma AI, van den Broek WW (2010). Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis. J Clin Psychopharmacol 30: 616-619.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
14. Imlah NW, Ryan E, Harrington JA (1965). The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Neuropsychopharmacol 4: 438-442.
15. Kay DW, Fahy T, Garside RF (1970). A seven-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry 117: 667-671.
16. Kellner CH (2013). Relapse after electroconvulsive therapy (ECT). J ECT 29: 1-2.
17. Kellner CH, Knapp R, Husain MM, Rasmussen K, Sampson S, Cullum M et al (2010). Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry 196: 226-234.
18. Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K et al (2006). Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 63: 1337-1344. (Pubitemid 44878518)
19. Krog-Meyer I, Kirkegaard C, Kijne B (1984). Prediction of relapse with the TRH test and prophylactic amitriptyline in 39 patients with endogenous depression. Am J Psychiatry 141: 945-948. (Pubitemid 14093698)
20. Lauritzen L, Odgaard K, Clemmesen L, Lunde M (1996). Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 94: 241-251. (Pubitemid 26344631)
21. Lisanby SH, Sampson S, Husain MM, Petrides G, Knapp RG, McCall WV et al (2008). Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention. J ECT 24: 179-182.
22. Loo CH, Katalinic N, Martin D, Schweitzer I (2012). A review of ultrabrief pulse width electroconvulsive therapy. Ther Adv Chronic Dis 3: 69-85.
23. Martinez-Amoros E, Cardoner N, Soria V, Galvez V, Menchon JM, Urretavizcaya M (2012). Long-term treatment strategies in major depression: a 2-year prospective naturalistic follow-up after successful electroconvulsive therapy. J ECT 28: 92-97.
24. Navarro V, Gastobal C, Torres X, Masana G, Penades R, Guarch J et al (2008). Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study. Am J Geriatr Psychiatry 16: 498-505.
25. Prudic J, Haskett RF, McCall WV, Isenberg K, Cooper T, Rosenquist PB et al (2013). Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J ECT 29: 3-12.
26. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S et al (1996). Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 153: 985-992. (Pubitemid 26264697)
27. Prudic J, Sackeim HA, Devanand DP (1990). Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 31: 287-296. (Pubitemid 20102377)
28. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D et al (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163: 1905-1917. (Pubitemid 44807782)
29. Sackeim HA (1994). Continuation therapy following ECT: directions for future research. Psychopharmacol Bull 30: 501-521.
30. Sackeim HA, Dillingham EM, Prudic J, Cooper T, McCall WV, Rosenquist P et al (2009). Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. Arch Gen Psychiatry 66: 729-737.
31. Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM et al (2001). Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 285: 1299-1307. (Pubitemid 32216144)
32. Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S (1990). The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 10: 96-104. (Pubitemid 20137605)
33. Seager CP, Bird RL (1962). Imipramine with electrical treatment in depression: a controlled trial. J Ment Sci 108: 704-707.
34. The UK ECT Review Group (2003). Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361: 799-808.
35. van den Broek WW, Birkenhager TK, Mulder PG, Bruijn JA, Moleman P (2006). Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial. J Clin Psychiatry 67: 263-268. (Pubitemid 43357473)
36. Wijkstra J, Nolen WA, Algra A, van Vliet IM, Kahn RS (2000). Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series. Acta Psychiatr Scand 102: 454-460.
37. Yildiz A, Mantar A, Simsek S, Onur E, Gokmen N, Fidaner H (2010). Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: a pilot controlled trial. J ECT 26: 104-110.